Search Orphan Drug Designations and Approvals
-
Generic Name: | Interferon alfa-2b (recombinant) |
---|---|
Date Designated: | 04/18/1988 |
Orphan Designation: | Treatment of invasive carcinoma of the cervix. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Schering Corporation 2000 Galloping Hill Road Kenilworth, New Jersey 07033 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-